کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4006580 1602339 2016 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis
ترجمه فارسی عنوان
انسداد ورید شبکیه مرکزی واسکولتیک: علائم ارائه شده از آرتریت روماتوئید سرومگنتیک
کلمات کلیدی
انسداد ورید مرکزی شبکیه (CRVO)؛ CRVO Vasculitic؛ آرتریت روماتوئید (RA)؛ آرتریت روماتوئید سرژوآنتی سنجش زیست سنج Vectra DA
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی چشم پزشکی
چکیده انگلیسی

PurposeTo report the case of a patient who presented with a vasculitic central retinal vein occlusion (CRVO), which was the result of an undiagnosed systemic inflammatory condition, seronegative rheumatoid arthritis (RA).ObservationsThe patient presented with reduced vision in the left eye and polyarthralgia. Fundoscopic examination revealed a central retinal vein occlusion (CRVO) with concurrent evidence of vasculitis. Work-up for polyarthralgia included comprehensive serologic testing for connective tissue disease, including Vectra® disease activity (DA) testing. Results of these studies confirmed the diagnosis of seronegative rheumatoid arthritis (RA). Systemic steroid therapy was initiated with subsequent anatomic and visual improvement.Conclusions and importanceWe hypothesize that the systemic inflammation—a hallmark of RA—led to the development of a vasculitic CRVO and, thus, the retinal manifestations served as the disease marker that prompted thorough work-up of the patient's disease, even in the face of initial seronegativity. This case serves as a reminder that, in the setting of CRVO and polyarthralgia, systemic inflammatory conditions must be considered as the underlying etiology. Further, this case report highlights our evolving understanding of the role that serologic markers play in the diagnosis and monitoring of RA.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: American Journal of Ophthalmology Case Reports - Volume 2, July 2016, Pages 26–29
نویسندگان
, , , ,